NeuroGyn Genital Neuromodulation System for iOAB Treatment

Sponsor
Prof. Dr. med. Marc Possover
Study ID
NCT06529198
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Overactive Bladder

Eligibility Criteria

Sex
ALL
Age
18 Years - 85 Years
Healthy Volunteers
Not accepted

Interventions

  • NeuroGyn Genital Neuromodulation System — DEVICE
    Genital Neuromodulation

Study Details

The NeuroGyn study is designed to evaluate the safety and effectiveness to the NeuroGyn Genital Neuromodulation System as an aid in the treatment of the symptoms of idiopathic overactive bladder in patients who have failed or could not tolerate more conservative treatments.

Key Dates

First listed
Jul 31, 2024
Start date
Aug 1, 2025
Status verified
Jul 2024
Primary completion
Feb 1, 2026
Completion
Apr 1, 2026

Study Design

Enrollment
150 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: treatment
    Patient are undergoing neuromodulatioon

Primary Outcome Measure

Reduction in Symptoms greater than or equal to 50% [ Time Frame: 6 months - 1 year - 2 years follow up ]

Central Contacts

Related Studies